Effect of Deep Friction Massage on Pain, Function, Kinesiophobia, and Quality of Life in Bicipital Tendinitis

April 26, 2026 updated by: Muharrem Gökhan Beydağı, Firat University

Investigation of the Effect of Deep Friction Massage Applied to Patients With Bicipital Tendinitis on Pain, Functional Capacity, Kinesiophobia, and Quality of Life

Bicipital tendinitis is a condition caused by inflammation of the biceps tendon, resulting in pain and limited movement in the front of the shoulder. This condition usually develops due to repetitive shoulder movements or overuse and can negatively affect daily life.

Treatment usually involves medications, cold applications, rest, and exercises. However, in some cases, these methods may not be sufficient. This study aims to investigate the effects of deep friction massage (DFM) when applied in addition to a standard exercise program. DFM is a massage technique that supports tissue healing, reduces pain, and improves mobility.

Within the scope of the study, the effects of DFM combined with exercise on pain, functional capacity, fear of movement (kinesiophobia), and quality of life will be evaluated. The findings obtained aim to contribute to the development of more effective approaches in the treatment of biceps tendinitis.

Study Overview

Status

Active, not recruiting

Detailed Description

Bicipital tendinitis is a condition characterized by inflammation of the long head of the biceps tendon, causing pain and tenderness in the front of the shoulder. It typically develops due to repetitive shoulder movements or overuse and, if left untreated, can negatively impact quality of life. Treatment for biceps tendinitis focuses on reducing inflammation and swelling, strengthening the tendon, and preventing tendon rupture. Early/initial treatments for biceps tendinitis include nonsteroidal anti-inflammatory drugs, activity modification, nonsteroidal anti-inflammatory gels or patches for pain, and cold applications for pain and swelling. If symptoms do not improve, physical therapy may be recommended. These treatments typically include stretching and strengthening exercises, massage, or ultrasound therapy. Exercises aim to help keep muscles, joints, and tendons mobile and flexible. If symptoms are severe or persistent despite initial/early treatment, the doctor may recommend a steroid injection into the affected area to reduce inflammation and pain. After the injection, patients are typically prescribed rest, ice, acetaminophen (Tylenol) for pain, and a regimen of stretching/strengthening exercises.

Another important treatment method in the conservative management of tendinopathies is Deep Friction Massage (DFM). DFM is an approach that mechanically supports the remodeling of tissue and the healing process. This technique helps meet the tendon's oxygen and nutrient requirements by increasing blood flow in the treated area, while supporting the alignment of collagen fibers and facilitating the reorganization of scar tissue. The effects of deep friction massage on pain reduction and functional capacity improvement have been extensively documented in the literature. Additionally, the positive effects of this method on flexibility and range of motion from a biomechanical perspective are one of the reasons it is preferred in the management of musculoskeletal disorders.

The investigators believe that the application of deep friction massage in addition to a standard exercise program in patients with bicipital tendinitis could be a useful combination therapy to support tendon healing. This approach may create a synergistic effect in tendon healing by combining the positive effects of exercise with the long-term tissue benefits of deep friction massage. There are a limited number of studies in the literature suggesting that this combination is effective; therefore, more comprehensive and controlled research is needed to guide clinical practice.

Pain, functional capacity, kinesiophobia (fear of movement), and quality of life are critical in assessing the effects of biceps tendinitis on patients. Improving these parameters can accelerate patients' return to daily activities and improve their overall health. In light of this information, it is thought that the combined application of an exercise program and deep friction massage could be considered a potential treatment strategy for pain management and functional improvement in the treatment of biceps tendinitis. This study aims to evaluate the effects of deep friction massage, applied in addition to an exercise program, on pain, functional capacity, kinesiophobia, and quality of life in patients with biceps tendinitis. This will provide further insight into the efficacy of combined treatment methods and guide clinical practice.

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Elâzığ, Merkez, Turkey (Türkiye), 23200
        • Fırat Üniversitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of bicipital tendinitis (tendinosis)
  • Be between 20 and 55 years of age
  • Have shoulder pain lasting longer than 3 months

Exclusion Criteria:

  • Shoulder impingement or frozen shoulder
  • Another shoulder problem such as a full-thickness rotator cuff tear or instability
  • Having received physical therapy or manual therapy for the same shoulder within the past year
  • History of upper extremity fracture
  • History of shoulder surgery
  • Presence of entrapment neuropathy
  • Having radicular pain originating from the cervical vertebrae
  • Having a systemic musculoskeletal disease
  • Having mental and cognitive problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Individuals in the control groups will be included in a routine exercise program. This exercise program will include shoulder joint range of motion exercises, finger ladder, Codman, and stick exercises, which will be applied to maintain functional range of motion in the early stages and increase it in the later stages. Isometric exercises will be applied to the scapular muscles to maintain muscle strength in the early stages. In the later stages, rotator cuff, scapular stabilizer, and deltoid strengthening exercises will be demonstrated and applied. Low-resistance therabands will be used for strengthening at the beginning. Additionally, neuromuscular control exercises and proprioceptive exercises will be included in the treatment to enhance joint stabilization and coordination. The exercises will be performed over a 6-week period, 3 days per week, with 10-30 repetitions.
Individuals in the control and intervention groups will be included in a routine exercise program. For this exercise program; shoulder joint range of motion exercises, finger ladder, Codman and stick exercises will be given to protect functional range of motion in the early stages and to increase it in the later stages. Isometric exercises will be performed on the scapular muscles in the early stages to preserve muscle strength. In the later stages, rotator cuff, scapula stabilizers and deltoid strengthening exercises will be shown and applied, initially with low-resistance therabants for strengthening. In addition, neuromuscular control exercises and proprioceptive exercises will be included in the treatment to increase joint stabilization and coordination. Exercises will be performed for 6 weeks, 3 days a week, with 10-30 repetitions.
Experimental: Intervention group
Individuals in the intervention group will receive deep friction massage on the biceps tendon in addition to the routine exercise program and following the exercise program. The individual will be placed in a long sitting position with their back supported. While the patient's shoulder is next to the body and the elbow is flexed at 90 degrees, the therapist's thumb will be placed on the painful area on the extension of the biceps tendon fibers and a deep friction massage will be applied to the point where the tendonitis occurs in a transverse direction for 3-10 minutes.
Individuals in the control and intervention groups will be included in a routine exercise program. For this exercise program; shoulder joint range of motion exercises, finger ladder, Codman and stick exercises will be given to protect functional range of motion in the early stages and to increase it in the later stages. Isometric exercises will be performed on the scapular muscles in the early stages to preserve muscle strength. In the later stages, rotator cuff, scapula stabilizers and deltoid strengthening exercises will be shown and applied, initially with low-resistance therabants for strengthening. In addition, neuromuscular control exercises and proprioceptive exercises will be included in the treatment to increase joint stabilization and coordination. Exercises will be performed for 6 weeks, 3 days a week, with 10-30 repetitions.
Individuals in the intervention group will receive a deep friction massage to the biceps tendon after the exercise program. The individual will be placed in a long sitting position with their back supported. While the patient's shoulder is next to the body and the elbow is flexed at 90 degrees, the therapist's thumb will be placed on the painful area on the extension of the biceps tendon fibers and a deep friction massage will be applied to the point where the tendonitis occurs in a transverse direction for 3-10 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Assessment
Time Frame: before-after treatment (baseline, 6th week and 12th week)
The Visual Analog Scale (VAS) will be used to determine the intensity of pain and to compare the pain felt before and after treatment (baseline, 6th week and 12th week). VAS is a reliable and easily applicable test used to measure values that cannot be easily measured numerically by converting them into a numerical format. The lowest and highest definitions of the parameters to be evaluated are written on both ends of a 100 mm line. The patient is asked to mark the most appropriate value (location) between these two extreme points. When this scale is used for pain, the numbers "0" are written on one end to indicate no pain and "10" are written on the other end to indicate the most severe pain, and this is converted into a template, numbers between 0-10 are placed on the line and the patient is asked to choose the closest number.
before-after treatment (baseline, 6th week and 12th week)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Functional Capacity
Time Frame: before and after treatment (at baseline, 6 weeks, and 12 weeks)

Individuals' functional capacities will be assessed using the Shoulder, Arm, and Hand Problems Short Form (Q-DASH).

Shoulder, Arm, and Hand Problems Short Form (Q-DASH):

The Quick DASH questionnaire, which is the short form of the Shoulder, Arm, and Hand Problems (DASH-T) questionnaire validated and tested for reliability in Turkish by Düger et al. (2006), will be used. The 11-item questionnaire subjectively assesses the functional status of the upper extremity using a Likert scale. Patients will be asked to complete the questionnaire themselves, and the total score obtained will be converted into a total score ranging from 0 to 100 using a formula developed for the questionnaire (Gummesson et al. 2004). Values closer to 0 indicate good functional outcomes.

before and after treatment (at baseline, 6 weeks, and 12 weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Normal Joint Movement
Time Frame: pre- and post-treatment (baseline, 6 weeks, and 12 weeks)
Individuals' normal shoulder joint range of motion will be measured using a digital goniometer. The active and passive range of motion of the shoulder in extension, flexion, abduction, adduction, internal, and external rotation will be assessed. The normal range of motion of the affected shoulder will be evaluated. Each test will be performed three times to ensure accuracy, and the average of the three measurements will be recorded.
pre- and post-treatment (baseline, 6 weeks, and 12 weeks)
Evaluation of Kinesiophobia
Time Frame: before and after treatment (at baseline, week 6, and week 12)
The short form of the Tampa Kinesiophobia Scale (TKÖ) will be used to assess individuals' kinesiophobia levels. The TKÖ is a measure developed in 1991 by Miller, Kopri, and Todd, but later republished by Vlaeyen et al., and used to assess fear of movement. The TKÖ consists of 17 questions. It includes questions related to injury/re-injury and fear-avoidance situations in work-related activities, and individuals answer them themselves. It is scored on a four-point Likert scale (1 = strongly disagree, 4 = strongly agree). At the end of the scale, a score between 17 and 68 is obtained, and high scores are defined as kinesiophobia.
before and after treatment (at baseline, week 6, and week 12)
Assessment of Quality of Life
Time Frame: before and after treatment (at baseline, week 6, and week 12)
The SF-12 questionnaire will be used to assess individuals' quality of life. Ware et al. (1995) developed a shortened version of the SF-36 quality of life questionnaire. Soylu et al. (2022) also examined the validity and reliability of the SF-12 Quality of Life Scale in Turkish. The SF-12 is a questionnaire used to assess individuals' general health status, physical and psychological functions, social activities, and quality of life. It consists of 12 questions, and the general health score is calculated based on the answers given to these questions. Thanks to the SF-12, the 36 items were reduced to 12 items, allowing participants to complete the questionnaire in less than one-third of the time spent on the SF-36. Ware demonstrated a strong correlation between the two tools, showing that approximately 90% of the variability in both the physical and mental component summaries of the SF-36 is explained by the same summary mea
before and after treatment (at baseline, week 6, and week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2024

Primary Completion (Estimated)

May 20, 2026

Study Completion (Estimated)

May 20, 2026

Study Registration Dates

First Submitted

June 12, 2025

First Submitted That Met QC Criteria

June 12, 2025

First Posted (Actual)

June 22, 2025

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 26, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to the small sample size and ethical restrictions regarding patient confidentiality in this single-center study, individual participant data will not be publicly shared. However, aggregated data will be available upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bicipital Tendonitis

Clinical Trials on Exercise

3
Subscribe